Xiaomei Li

9.3k total citations · 1 hit paper
220 papers, 4.7k citations indexed

About

Xiaomei Li is a scholar working on Immunology, Rheumatology and Physiology. According to data from OpenAlex, Xiaomei Li has authored 220 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Immunology, 52 papers in Rheumatology and 42 papers in Physiology. Recurrent topics in Xiaomei Li's work include Systemic Lupus Erythematosus Research (34 papers), Salivary Gland Disorders and Functions (24 papers) and Immune Cell Function and Interaction (15 papers). Xiaomei Li is often cited by papers focused on Systemic Lupus Erythematosus Research (34 papers), Salivary Gland Disorders and Functions (24 papers) and Immune Cell Function and Interaction (15 papers). Xiaomei Li collaborates with scholars based in China, United States and Australia. Xiaomei Li's co-authors include Hai‐Feng Pan, Xiang-Pei Li, Dong‐Qing Ye, Peng Wang, Zongwen Shuai, Rui‐Xue Leng, Yue Chen, Zhiwei Xu, Jin‐Hui Tao and Xiang Meng and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Xiaomei Li

216 papers receiving 4.7k citations

Hit Papers

New‐onset autoimmune phenomena post‐COVID‐19 vaccination 2021 2026 2022 2024 2021 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaomei Li China 37 1.3k 1.2k 785 609 571 220 4.7k
Tommaso Trenti Italy 35 1.3k 1.0× 531 0.4× 303 0.4× 563 0.9× 735 1.3× 196 5.1k
Daniel M. Levine United States 35 937 0.7× 925 0.8× 659 0.8× 582 1.0× 248 0.4× 86 4.3k
Hui Peng China 35 1.4k 1.1× 393 0.3× 334 0.4× 522 0.9× 415 0.7× 205 4.2k
Salvatore Benvenga Italy 48 1.5k 1.2× 585 0.5× 494 0.6× 583 1.0× 728 1.3× 333 9.6k
Lei Wang China 42 3.3k 2.6× 833 0.7× 444 0.6× 614 1.0× 658 1.2× 310 6.5k
Xiaoyan Cai China 38 1.5k 1.1× 796 0.7× 371 0.5× 379 0.6× 731 1.3× 140 5.2k
Barbara Obermayer‐Pietsch Austria 49 2.2k 1.7× 541 0.5× 382 0.5× 897 1.5× 1.6k 2.9× 259 8.6k
Hitoshi Ando Japan 44 1.8k 1.4× 1.5k 1.3× 739 0.9× 1.7k 2.8× 649 1.1× 255 8.1k
Mark S. Cooper United Kingdom 42 1.4k 1.1× 395 0.3× 390 0.5× 608 1.0× 584 1.0× 135 7.2k
Alessandro Allegra Italy 37 1.9k 1.5× 710 0.6× 228 0.3× 334 0.5× 985 1.7× 263 5.0k

Countries citing papers authored by Xiaomei Li

Since Specialization
Citations

This map shows the geographic impact of Xiaomei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaomei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaomei Li more than expected).

Fields of papers citing papers by Xiaomei Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaomei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaomei Li. The network helps show where Xiaomei Li may publish in the future.

Co-authorship network of co-authors of Xiaomei Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaomei Li. A scholar is included among the top collaborators of Xiaomei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaomei Li. Xiaomei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tan, Zhen, Nan Xiang, Xiang Yuan, et al.. (2025). Risk of heart disease in neonates born to mothers with primary Sjögren’s syndrome: a multicenter retrospective study. Lara D. Veeken. 64(10). 5277–5286.
4.
Li, Xiaomei, et al.. (2024). Research progress and future directions of immune checkpoint inhibitor combination therapy in advanced gastric cancer. Therapeutic Advances in Medical Oncology. 16. 12710892–12710892. 4 indexed citations
5.
Liu, Xia, et al.. (2024). Annexin A1: a key regulator of T cell function and bone marrow adiposity in aplastic anaemia. The Journal of Physiology. 602(22). 6125–6152.
6.
Cai, Minglong, Xin Wang, Zhijun Li, et al.. (2024). Effectiveness and safety of Belimumab and Telitacicept in systemic lupus erythematosus: a real-world, retrospective, observational study. Clinical Rheumatology. 44(1). 247–256. 3 indexed citations
7.
Liu, Muziying, Chenwen Zhu, Huimin Zhang, et al.. (2023). Regulatory mucosa-associated invariant T cells controlled by β1 adrenergic receptor signaling contribute to hepatocellular carcinoma progression. Hepatology. 78(1). 72–87. 18 indexed citations
8.
Li, Yujing, Xin Wang, Zhijun Li, et al.. (2023). Efficacy and safety of telitacicept in patients with systemic lupus erythematosus: a multicentre, retrospective, real-world study. Lupus Science & Medicine. 10(2). e001074–e001074. 21 indexed citations
9.
Ma, Xiaoxiao, Shuqin Jia, Min Liang, et al.. (2023). TRIM28 promotes the escape of gastric cancer cells from immune surveillance by increasing PD-L1 abundance. Signal Transduction and Targeted Therapy. 8(1). 246–246. 51 indexed citations
11.
Fang, Xuan, Yuan Xia, Manyun Li, et al.. (2022). ATP-Activated P2X7R Promote the Attack of Acute Gouty Arthritis in Rats Through Activating NLRP3 Inflammasome and Inflammatory Cytokine Production. Journal of Inflammation Research. Volume 15. 1237–1248. 13 indexed citations
13.
Cui, Jing, Rui Dong, Dong Wang, et al.. (2020). Analysis of clinical and genetic characteristics in 10 Chinese individuals with Cornelia de Lange syndrome and literature review. Molecular Genetics & Genomic Medicine. 8(10). e1471–e1471. 7 indexed citations
14.
Li, Xiaomei, et al.. (2017). B7‐H4 deficiency in salivary gland of patients with primary Sjögren's syndrome impairs the regulatory effect on T cells. International Journal of Rheumatic Diseases. 20(4). 474–480. 6 indexed citations
15.
Luo, Jun‐Yi, Rui‐Hua Xu, Xiaomei Li, et al.. (2016). MIF Gene Polymorphism rs755622 Is Associated With Coronary Artery Disease and Severity of Coronary Lesions in a Chinese Kazakh Population. Medicine. 95(4). e2617–e2617. 17 indexed citations
16.
Zhou, Jingjing, Guosheng Wang, Xiang-Pei Li, Xiaomei Li, & Long Qian. (2013). Changes of plasmacytoid dendritic cells in peripheral blood and its role in the pathogenesis of systemic lupus erythematosus. Zhonghua weishengwuxue he mianyixue zazhi. 33(5). 334–338. 1 indexed citations
17.
Yan, Yan, Huidi Liu, Xuefeng Cao, et al.. (2011). Expression of G Protein-coupled Receptor 30(GPR30)in Epithelial Ovarian Carcinoma and Its Correlation with Proliferation Associated Genes c-fos and CyclinD1. 31(4). 236–240. 1 indexed citations
18.
Li, Xiaomei, Xiang-Pei Li, Long Qian, et al.. (2007). [Expression of CD4+ CD25+ regulatory T cells in peripheral blood and salivary gland of patients with primary Sjögren's syndrome].. PubMed. 87(15). 1034–6. 5 indexed citations
19.
Wang, Xiaoqiu, Xiaomei Li, Xiang-Pei Li, et al.. (2007). [Immunopathology of labial glands of patients with primary Sjögren's syndrome].. PubMed. 87(35). 2505–7. 1 indexed citations
20.
Yang, Wentao, et al.. (1998). Detection of telomerase activity in breast carcinoma. Chinese Journal of Cancer Research. 10(4). 292–296. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026